Strategic partnerships PatientMpower has established collaborations with major health institutions such as Manchester Foundation Trust and UZ Leuven, indicating a proven pathway for joint deployments and expansion into additional leading centers. Use these relationships to position complementary remote monitoring solutions to similar large-scale hospitals and transplant centers.

AI growth The company is actively developing AI powered tools for lung disease prediction, signaling an expanding product roadmap. This presents an opportunity to upsell advanced analytics modules or data integration services to healthcare providers seeking predictive insights and proactive care.

Home monitoring depth Current offerings enable home measurements via spirometers and pulse oximeters integrated with a mobile app and EMR connections, which aligns with hospitals aiming to reduce outpatient visits and optimize remote care pathways. This suggests cross selling to centers pursuing remote monitoring scale and EMR interoperability enhancements.

Regulatory minded Longstanding collaboration with NHS and international centers demonstrates credibility in regulated healthcare environments. Leverage this to approach additional public and private health systems with compliant telehealth and data integration solutions, especially in respiratory care.

Scaling potential Revenue is currently under one million with a small to mid sized team, implying a prime target for scalable deployments, managed services, or channel partnerships to accelerate growth in new geographies or larger transplant programs while maintaining personalized support.